Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Ip6k2 | Rat | (+)-catechin | multiple interactions | ISO | IP6K2 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of IP6K2 mRNA | CTD | PMID:24763279 | Ip6k2 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | IP6K2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of IP6K2 mRNA | CTD | PMID:22079256 | Ip6k2 | Rat | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | decreases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in decreased expression of IP6K2 mRNA | CTD | PMID:25575267 | Ip6k2 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of IP6K2 mRNA | CTD | PMID:22206623 | Ip6k2 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Ip6k2 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IP6K2 mRNA | CTD | PMID:22206623 | Ip6k2 | Rat | 17beta-estradiol | decreases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of IP6K2 mRNA | CTD | PMID:23019147|PMID:31614463 | Ip6k2 | Rat | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of IP6K2 mRNA | CTD | PMID:32145629 | Ip6k2 | Rat | 17beta-estradiol | decreases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | Estradiol results in decreased expression of IP6K2 mRNA | CTD | PMID:25575267|PMID:39298647 | Ip6k2 | Rat | 17beta-estradiol | affects expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Estradiol affects the expression of IP6K2 mRNA | CTD | PMID:22574217 | Ip6k2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of IP6K2 mRNA | CTD | PMID:21215274|PMID:33387578 | Ip6k2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IP6K2 mRNA | CTD | PMID:32109520 | Ip6k2 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of IP6K2 mRNA | CTD | PMID:22574217 | Ip6k2 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of IP6K2 mRNA | CTD | PMID:21346803 | Ip6k2 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of IP6K2 mRNA | CTD | PMID:21346803 | Ip6k2 | Rat | 2-methylcholine | affects expression | ISO | IP6K2 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of IP6K2 mRNA | CTD | PMID:21179406 | Ip6k2 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of IP6K2 mRNA | CTD | PMID:39298647 | Ip6k2 | Rat | 4,4'-sulfonyldiphenol | increases methylation | ISO | IP6K2 (Homo sapiens) | 6480464 | bisphenol S results in increased methylation of IP6K2 gene | CTD | PMID:31601247 | Ip6k2 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of IP6K2 mRNA | CTD | PMID:28973697 | Ip6k2 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of IP6K2 mRNA | CTD | PMID:25825206 | Ip6k2 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of IP6K2 mRNA | CTD | PMID:30047161 | Ip6k2 | Rat | acrylamide | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of IP6K2 mRNA | CTD | PMID:32763439 | Ip6k2 | Rat | aflatoxin B1 | decreases methylation | ISO | IP6K2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of IP6K2 gene | CTD | PMID:27153756 | Ip6k2 | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of IP6K2 mRNA | CTD | PMID:30047161 | Ip6k2 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of IP6K2 mRNA | CTD | PMID:16483693 | Ip6k2 | Rat | antirheumatic drug | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of IP6K2 mRNA | CTD | PMID:24449571 | Ip6k2 | Rat | aristolochic acid A | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of IP6K2 mRNA | CTD | PMID:33212167 | Ip6k2 | Rat | arsane | affects methylation | ISO | IP6K2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of IP6K2 gene | CTD | PMID:25304211 | Ip6k2 | Rat | arsane | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Arsenic results in increased expression of IP6K2 mRNA | CTD | PMID:31739468 | Ip6k2 | Rat | arsane | multiple interactions | ISO | IP6K2 (Homo sapiens) | 6480464 | [Arsenic co-treated with Iron] results in increased expression of IP6K2 mRNA; [sodium arsenite results in more ... | CTD | PMID:31739468|PMID:39836092 | Ip6k2 | Rat | arsenic atom | affects methylation | ISO | IP6K2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of IP6K2 gene | CTD | PMID:25304211 | Ip6k2 | Rat | arsenic atom | multiple interactions | ISO | IP6K2 (Homo sapiens) | 6480464 | [Arsenic co-treated with Iron] results in increased expression of IP6K2 mRNA; [sodium arsenite results in more ... | CTD | PMID:31739468|PMID:39836092 | Ip6k2 | Rat | arsenic atom | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Arsenic results in increased expression of IP6K2 mRNA | CTD | PMID:31739468 | Ip6k2 | Rat | benzo[a]pyrene | decreases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of IP6K2 mRNA | CTD | PMID:19770486 | Ip6k2 | Rat | benzo[a]pyrene diol epoxide I | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of IP6K2 mRNA | CTD | PMID:19150397 | Ip6k2 | Rat | beta-lapachone | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of IP6K2 mRNA | CTD | PMID:38218311 | Ip6k2 | Rat | bisphenol A | decreases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of IP6K2 mRNA | CTD | PMID:25575267 | Ip6k2 | Rat | bisphenol A | increases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of IP6K2 mRNA | CTD | PMID:33221593 | Ip6k2 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of IP6K2 mRNA | CTD | PMID:32145629 | Ip6k2 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of IP6K2 mRNA | CTD | PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585 | Ip6k2 | Rat | bisphenol A | affects expression | ISO | IP6K2 (Homo sapiens) | 6480464 | bisphenol A affects the expression of IP6K2 mRNA | CTD | PMID:30903817 | Ip6k2 | Rat | bisphenol A | decreases methylation | ISO | Ip6k2 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of IP6K2 promoter | CTD | PMID:27312807 | Ip6k2 | Rat | bromobenzene | affects expression | EXP | | 6480464 | bromobenzene affects the expression of IP6K2 mRNA | CTD | PMID:32479839 | Ip6k2 | Rat | cadmium atom | multiple interactions | ISO | Ip6k2 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IP6K2 more ... | CTD | PMID:37236586 | Ip6k2 | Rat | cadmium dichloride | decreases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of IP6K2 mRNA | CTD | PMID:38568856 | Ip6k2 | Rat | cadmium dichloride | multiple interactions | ISO | Ip6k2 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IP6K2 more ... | CTD | PMID:37236586 | Ip6k2 | Rat | chlorpyrifos | increases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of IP6K2 mRNA | CTD | PMID:37019170 | Ip6k2 | Rat | ciguatoxin CTX1B | affects expression | ISO | Ip6k2 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of IP6K2 mRNA | CTD | PMID:18353800 | Ip6k2 | Rat | clotrimazole | decreases expression | EXP | | 6480464 | Clotrimazole results in decreased expression of IP6K2 mRNA | CTD | PMID:30047161 | Ip6k2 | Rat | cobalt dichloride | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of IP6K2 mRNA | CTD | PMID:19320972 | Ip6k2 | Rat | copper(II) sulfate | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of IP6K2 mRNA | CTD | PMID:19549813 | Ip6k2 | Rat | coumestrol | multiple interactions | ISO | IP6K2 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IP6K2 mRNA | CTD | PMID:19167446 | Ip6k2 | Rat | coumestrol | decreases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of IP6K2 mRNA | CTD | PMID:19167446 | Ip6k2 | Rat | crocidolite asbestos | decreases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | Asbestos, Crocidolite results in decreased expression of IP6K2 mRNA | CTD | PMID:29279043 | Ip6k2 | Rat | cyclosporin A | decreases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of IP6K2 mRNA | CTD | PMID:27989131 | Ip6k2 | Rat | DDE | decreases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of IP6K2 mRNA | CTD | PMID:38568856 | Ip6k2 | Rat | Dibutyl phosphate | affects expression | ISO | IP6K2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of IP6K2 mRNA | CTD | PMID:37042841 | Ip6k2 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of IP6K2 mRNA | CTD | PMID:21266533 | Ip6k2 | Rat | diethylstilbestrol | decreases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | Diethylstilbestrol results in decreased expression of IP6K2 mRNA | CTD | PMID:25575267 | Ip6k2 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of IP6K2 mRNA | CTD | PMID:29391264 | Ip6k2 | Rat | endosulfan | affects expression | EXP | | 6480464 | Endosulfan affects the expression of IP6K2 mRNA | CTD | PMID:31464424 | Ip6k2 | Rat | Enterolactone | multiple interactions | ISO | IP6K2 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IP6K2 mRNA | CTD | PMID:19167446 | Ip6k2 | Rat | erythromycin estolate | decreases expression | EXP | | 6480464 | Erythromycin Estolate results in decreased expression of IP6K2 mRNA | CTD | PMID:24412560 | Ip6k2 | Rat | estriol | decreases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | Estriol results in decreased expression of IP6K2 mRNA | CTD | PMID:25575267 | Ip6k2 | Rat | ethanol | affects splicing | ISO | Ip6k2 (Mus musculus) | 6480464 | Ethanol affects the splicing of IP6K2 mRNA | CTD | PMID:30319688 | Ip6k2 | Rat | ethyl methanesulfonate | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of IP6K2 mRNA | CTD | PMID:23649840 | Ip6k2 | Rat | fenthion | increases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | Fenthion results in increased expression of IP6K2 mRNA | CTD | PMID:34813904 | Ip6k2 | Rat | folic acid | multiple interactions | ISO | Ip6k2 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IP6K2 mRNA | CTD | PMID:22206623 | Ip6k2 | Rat | formaldehyde | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of IP6K2 mRNA | CTD | PMID:23649840 | Ip6k2 | Rat | gallic acid | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Gallic Acid results in increased expression of IP6K2 mRNA | CTD | PMID:34408198 | Ip6k2 | Rat | iron atom | multiple interactions | ISO | IP6K2 (Homo sapiens) | 6480464 | [Arsenic co-treated with Iron] results in increased expression of IP6K2 mRNA | CTD | PMID:31739468 | Ip6k2 | Rat | iron(0) | multiple interactions | ISO | IP6K2 (Homo sapiens) | 6480464 | [Arsenic co-treated with Iron] results in increased expression of IP6K2 mRNA | CTD | PMID:31739468 | Ip6k2 | Rat | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of IP6K2 mRNA | CTD | PMID:24136188 | Ip6k2 | Rat | levofloxacin | increases expression | EXP | | 6480464 | Levofloxacin results in increased expression of IP6K2 mRNA | CTD | PMID:24136188 | Ip6k2 | Rat | methidathion | increases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | methidathion results in increased expression of IP6K2 mRNA | CTD | PMID:34813904 | Ip6k2 | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of IP6K2 mRNA | CTD | PMID:30047161 | Ip6k2 | Rat | methyl methanesulfonate | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of IP6K2 mRNA | CTD | PMID:23649840 | Ip6k2 | Rat | Methylazoxymethanol acetate | decreases expression | EXP | | 6480464 | Methylazoxymethanol Acetate results in decreased expression of IP6K2 mRNA | CTD | PMID:28349193 | Ip6k2 | Rat | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of IP6K2 mRNA | CTD | PMID:20360939 | Ip6k2 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of IP6K2 mRNA] | CTD | PMID:20360939 | Ip6k2 | Rat | okadaic acid | decreases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of IP6K2 mRNA | CTD | PMID:38832940 | Ip6k2 | Rat | orphenadrine | affects expression | EXP | | 6480464 | Orphenadrine affects the expression of IP6K2 mRNA | CTD | PMID:23665939 | Ip6k2 | Rat | oxycodone | increases expression | EXP | | 6480464 | Oxycodone results in increased expression of IP6K2 mRNA | CTD | PMID:23439660 | Ip6k2 | Rat | paracetamol | affects expression | ISO | Ip6k2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of IP6K2 mRNA | CTD | PMID:17562736 | Ip6k2 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of IP6K2 mRNA | CTD | PMID:33387578 | Ip6k2 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ip6k2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of IP6K2 mRNA | CTD | PMID:36331819 | Ip6k2 | Rat | phenethyl caffeate | multiple interactions | EXP | | 6480464 | caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of IP6K2 mRNA] | CTD | PMID:20360939 | Ip6k2 | Rat | phenformin | decreases expression | EXP | | 6480464 | Phenformin results in decreased expression of IP6K2 mRNA | CTD | PMID:31324951 | Ip6k2 | Rat | phenobarbital | affects expression | ISO | Ip6k2 (Mus musculus) | 6480464 | Phenobarbital affects the expression of IP6K2 mRNA | CTD | PMID:23091169 | Ip6k2 | Rat | pirinixic acid | increases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of IP6K2 mRNA | CTD | PMID:18301758|PMID:23811191 | Ip6k2 | Rat | potassium chromate | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of IP6K2 mRNA | CTD | PMID:22079256 | Ip6k2 | Rat | potassium chromate | multiple interactions | ISO | IP6K2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of IP6K2 mRNA | CTD | PMID:22079256 | Ip6k2 | Rat | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of IP6K2 mRNA | CTD | PMID:28903501 | Ip6k2 | Rat | quercetin | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Quercetin results in increased expression of IP6K2 mRNA | CTD | PMID:21632981 | Ip6k2 | Rat | ritodrine | increases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | Ritodrine results in increased expression of IP6K2 mRNA | CTD | PMID:23370008 | Ip6k2 | Rat | silicon dioxide | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Silicon Dioxide results in increased expression of IP6K2 mRNA | CTD | PMID:25351596 | Ip6k2 | Rat | silver atom | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Silver results in increased expression of IP6K2 mRNA | CTD | PMID:26014281 | Ip6k2 | Rat | silver(0) | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Silver results in increased expression of IP6K2 mRNA | CTD | PMID:26014281 | Ip6k2 | Rat | sodium arsenite | multiple interactions | ISO | IP6K2 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of IP6K2 more ... | CTD | PMID:39836092 | Ip6k2 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of IP6K2 mRNA | CTD | PMID:19281266 | Ip6k2 | Rat | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of IP6K2 mRNA | CTD | PMID:30047161 | Ip6k2 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of IP6K2 mRNA | CTD | PMID:31150632 | Ip6k2 | Rat | tetrachloromethane | increases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of IP6K2 mRNA | CTD | PMID:31919559 | Ip6k2 | Rat | triphenyl phosphate | affects expression | ISO | IP6K2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of IP6K2 mRNA | CTD | PMID:37042841 | Ip6k2 | Rat | triptonide | decreases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | triptonide results in decreased expression of IP6K2 mRNA | CTD | PMID:33045310 | Ip6k2 | Rat | troglitazone | decreases expression | ISO | Ip6k2 (Mus musculus) | 6480464 | troglitazone results in decreased expression of IP6K2 mRNA | CTD | PMID:28973697 | Ip6k2 | Rat | trovafloxacin | increases expression | EXP | | 6480464 | trovafloxacin results in increased expression of IP6K2 mRNA | CTD | PMID:24136188 | Ip6k2 | Rat | urethane | increases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Urethane results in increased expression of IP6K2 mRNA | CTD | PMID:28818685 | Ip6k2 | Rat | valdecoxib | decreases expression | EXP | | 6480464 | valdecoxib results in decreased expression of IP6K2 mRNA | CTD | PMID:24136188 | Ip6k2 | Rat | valproic acid | decreases expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of IP6K2 mRNA | CTD | PMID:23179753|PMID:28001369 | Ip6k2 | Rat | valproic acid | affects expression | ISO | IP6K2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of IP6K2 mRNA | CTD | PMID:25979313 | Ip6k2 | Rat | valproic acid | decreases methylation | ISO | IP6K2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of IP6K2 gene | CTD | PMID:29154799 | Ip6k2 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of IP6K2 mRNA | CTD | PMID:23034163 | Ip6k2 | Rat | zinc atom | multiple interactions | ISO | IP6K2 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of IP6K2 mRNA | CTD | PMID:18593933 | Ip6k2 | Rat | zinc(0) | multiple interactions | ISO | IP6K2 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of IP6K2 mRNA | CTD | PMID:18593933 | |






















